222 related articles for article (PubMed ID: 3330945)
1. [Immunoscintigraphy, an aid to the oncologist--the Rennes experience in using anti-CEA, anti-CA 19.9 monoclonal antibodies and radiolabelled OC-125].
Herry JY; Bourguet P; Kerbrat P; Le Prise E; Ben Hassel M; Gedouin D; Richier JL
Allerg Immunol (Paris); 1987 May; 19(5):180-8. PubMed ID: 3330945
[TBL] [Abstract][Full Text] [Related]
2. Detection of colorectal carcinoma by emission-computerized tomography after injection of 123I-labeled Fab or F(ab')2 fragments from monoclonal anti-carcinoembryonic antigen antibodies.
Delaloye B; Bischof-Delaloye A; Buchegger F; von Fliedner V; Grob JP; Volant JC; Pettavel J; Mach JP
J Clin Invest; 1986 Jan; 77(1):301-11. PubMed ID: 3484753
[TBL] [Abstract][Full Text] [Related]
3. Immunoscintigraphy of gastric or colon carcinoma with F(ab')2 fragments of anti-CEA monoclonal antibody.
Amendolagine F; Allegra V; Tenti M; Lobrano V; Pannozzo G
Rays; 1987; 12(1):67-71. PubMed ID: 3628863
[No Abstract] [Full Text] [Related]
4. Targeting of human breast cancer by a bispecific antibody directed against two tumour-associated antigens: ErbB-2 and carcinoembryonic antigen.
Dorvillius M; Garambois V; Pourquier D; Gutowski M; Rouanet P; Mani JC; Pugnière M; Hynes NE; Pèlegrin A
Tumour Biol; 2002; 23(6):337-47. PubMed ID: 12677091
[TBL] [Abstract][Full Text] [Related]
5. Anti-carcinoembryonic antigen immunoscintigraphy (technetium-99m-monoclonal antibody BW 431/26) and serum CEA levels in patients with suspected primary and recurrent colorectal carcinoma.
Lind P; Lechner P; Arian-Schad K; Klimpfinger M; Cesnik H; Kammerhuber F; Eber O
J Nucl Med; 1991 Jul; 32(7):1319-25. PubMed ID: 2066784
[TBL] [Abstract][Full Text] [Related]
6. Immunoscintigraphy with 99Tcm-labelled monoclonal anti-CEA BW 431/26 antibodies in patients with suspected recurrent and metastatic colorectal carcinoma: two-year follow-up.
Lacić M; Bokulić T; Lukac J; Baum RP; Kusić Z
Nucl Med Commun; 1999 Sep; 20(9):859-65. PubMed ID: 10533193
[TBL] [Abstract][Full Text] [Related]
7. Immunoscintigraphy using 99mTc-labeled anti-CEA monoclonal antibody for patients with colorectal cancer.
Takenoshita S; Hashizume T; Asao T; Nakamura J; Katoh R; Oriuchi N; Ootake H; Inoue T; Watanabe N; Endo K
Anticancer Res; 1995; 15(2):471-5. PubMed ID: 7763024
[TBL] [Abstract][Full Text] [Related]
8. Radioimmunoscintigraphy using monoclonal antibodies to CEA, CA 19-9 and CA 125.
Baum RP; Lorenz M; Hottenrott C; Albrecht M; Senekowitsch R; Happ J; Hertel A; Spitz J; Hör G
Int J Biol Markers; 1988; 3(3):177-84. PubMed ID: 3230337
[TBL] [Abstract][Full Text] [Related]
9. [Immunoscintigraphy of cancer of the ovaries and colon using labeled monoclonal antibodies].
Gabuniia RI; Shiriaev SV; Bogdasarov IuB; Zhordaniia KI; Anan'ev VS
Med Radiol (Mosk); 1989 Aug; 34(8):56-61. PubMed ID: 2770446
[TBL] [Abstract][Full Text] [Related]
10. Immunoscintigraphy of colon carcinoma.
Chatal JF; Saccavini JC; Fumoleau P; Douillard JY; Curtet C; Kremer M; Le Mevel B; Koprowski H
J Nucl Med; 1984 Mar; 25(3):307-14. PubMed ID: 6366160
[TBL] [Abstract][Full Text] [Related]
11. Immunoscintigraphy of colorectal carcinoma with F (ab')2 fragments of anti-CEA monoclonal antibody.
Buraggi G; Callegaro L; Turrin A; Gennari L; Bombardieri E; Mariani G; Deleide G; Dovis M; Gasparini M; Doci R
Cancer Detect Prev; 1987; 10(5-6):335-45. PubMed ID: 3568032
[TBL] [Abstract][Full Text] [Related]
12. Tumor scintigraphy with 131I anti CEA monoclonal antibodies and F(ab')2 in colorectal cancer.
Henze E; Kübel R; Waitzinger J; Büchler M; Adam WE; Beger HG
Eur J Nucl Med; 1987; 13(3):125-9. PubMed ID: 3622555
[TBL] [Abstract][Full Text] [Related]
13. [Immunoscintigraphy using radio-labeled monoclonal antibodies. Development of a method of cancer diagnosis and hopes for a new form of therapy].
Mach JP; Bischof-Delaloye A; Curchod S; Studer A; Grob JP; Volant JC; Mosimann F; Givel JC; Douglas P; Leyvraz S
Schweiz Med Wochenschr; 1987 Jul; 117(29):1076-86. PubMed ID: 3499666
[TBL] [Abstract][Full Text] [Related]
14. Immunoscintigraphy of primary and metastatic colorectal cancers with radiolabelled monoclonal antibodies anti-CEA.
Riva P; Moscatelli G; Agostini M; Spinelli A; Franceschi G
Acta Gastroenterol Belg; 1989; 52(5-6):497-505. PubMed ID: 2486018
[TBL] [Abstract][Full Text] [Related]
15. Clinical results of immunoscintigraphy in a variety of malignant tumors with special reference to immunohistochemistry.
Biersack HJ; Bockisch A; Oehr P; Knoblich A; Hartlapp J; Biltz H; Jaeger N; Bellmann O; Vogel J; Björklund B
Nuklearmedizin; 1986 Oct; 25(5):167-71. PubMed ID: 3540857
[TBL] [Abstract][Full Text] [Related]
16. Immunoscintigraphy using a technetium-99m labelled monoclonal anti-CEA antibody in the follow-up of colorectal cancer and other tumours producing CEA.
Hertel A; Baum RP; Lorenz M; Baew-Christow T; Encke A; Hör G
Br J Cancer Suppl; 1990 Jul; 10():34-6. PubMed ID: 2166552
[TBL] [Abstract][Full Text] [Related]
17. Metastatic colorectal cancer: radioimmunoscintigraphy with a stabilized In-111-labeled F(ab')2 fragment of an anti-CEA monoclonal antibody.
Lamki LM; Patt YZ; Rosenblum MG; Shanken LJ; Thompson LB; Schweighardt SA; Frincke JM; Murray JL
Radiology; 1990 Jan; 174(1):147-51. PubMed ID: 2294542
[TBL] [Abstract][Full Text] [Related]
18. [Localization of radiolabeled antibody to carcinoembryonic antigen in patients with gastrointestinal carcinoma].
Ohashi A
Nihon Geka Gakkai Zasshi; 1986 Mar; 87(3):297-306. PubMed ID: 3713682
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies to carcinoembryonic antigen: ionic strength as a factor in the selection of antibodies for immunoscintigraphy.
Haskell CM; Buchegger F; Schreyer M; Carrel S; Mach JP
Cancer Res; 1983 Aug; 43(8):3857-64. PubMed ID: 6344991
[TBL] [Abstract][Full Text] [Related]
20. [99mTc anti-carcinoembryonic antigen in colorectal cancer].
Frederiksen PB; Rasmussen JW; Lassen E; Fenger C; Kronborg O; Ditzel H
Ugeskr Laeger; 1994 Mar; 156(11):1641-5. PubMed ID: 8009660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
